No Data
Guangdong Transtek Medical Electronics (300562.SZ): The continuation application for the medical instruments production license submitted by Ruikang Hongye has been approved.
On November 18, Gelonghui reported that Guangdong Transtek Medical Electronics (300562.SZ) announced that its holding subsidiary, Shenzhen Ruikang Hongye Technology Development Co., Ltd. (hereinafter referred to as "Ruikang Hongye" or "subsidiary"), recently received the "Medical Instruments Production License" issued by the Guangdong Provincial Pharmaceutical Supervision Administration (License No.: Yue Shi Yao Jian Xie Sheng Chan Xu 20142566). It has been confirmed that the application for the renewal of the medical instruments production license by Ruikang Hongye has been approved.
Lexin Healthcare: Report for the third quarter of 2024
Express News | guangdong transtek medical electronics: net income for the first three quarters was 50.5273 million yuan, a year-on-year increase of 232.83%.
Guangdong Transtek Medical Electronics (300562.SZ): Lepu OTC hearing aids have achieved innovative functions such as adaptive hearing tests, automatic adaptation, and user hearing data tracking.
格隆汇October 16th | guangdong transtek medical electronics (300562.SZ) stated in the investor relations that the company focuses on the digital chronic disease management sector, deeply integrating health IoT, big data, AI, and medical services, accelerating the commercial application of cardiovascular digital chronic disease services. Currently, the main directions of AI technology application are: (1) Applied to medical diagnosis: mainly in the remote electrocardiogram service sector - dynamic electrocardiogram diagnosis (self-developed AI algorithm), innovative wearable electrocardiographic devices as carriers, leading AI algorithms as pioneers, focusing on solving critical diseases such as heart disease, stroke, etc.
Guangdong Transtek Medical Electronics (300562.SZ): owns asia vets ECG smart clothing, real-time dynamic ECG (4G Holter), dynamic blood pressure, and other professional medical-grade equipment and ECG monitoring service platform.
Gelonghui October 16th, guangdong transtek medical electronics (300562.SZ) stated in investor relations that the company focuses on the digital chronic disease management sector, and the remote dynamic electrocardiogram business sector is one of the company's global strategic business sectors. Currently, the company owns professional medical-grade equipment such as smart electrocardiogram garments, real-time dynamic electrocardiograms (4G Holter), dynamic electrocardiograms, electrocardiogram networks, smart heart patches, dynamic blood pressure, and heart monitoring service platforms within this sector. Currently, the core product of this business segment, the 'Twelve-Lead Smart Electrocardiogram Garment* (iSENSE Series),' has officially obtained a Class II medical device registration certificate from the Guangdong Provincial Pharmaceutical Administration, at the same time heart
Guangdong Transtek Medical Electronics (300562.SZ): Repurchase completed, has repurchased 1.11% of the shares.
Guangdong Transtek Medical Electronics (300562.SZ) announced on October 11 that, as of October 9, 2024, the company's share repurchase program has been fully implemented. As of October 9, 2024, the company has repurchased a total of 2.4122 million shares through a centralized bidding method using a repurchase dedicated securities account, accounting for 1.11% of the company's current total share capital (which is 217,466,188 shares). From the initial repurchase to October 9, 2024, the highest fill price for repurchasing shares was 13.24 yuan per share, and the lowest fill price was 6.05 yuan per share.
No Data
No Data